J&J sues to protect $74M franchise

Johnson & Johnson Innovative Medicine has taken steps to protect a $74 million franchise from early competition.

A lawsuit filed in the Federal Court under the former name of J&J's pharmaceutical arrm, Janssen, claims that Juno has threatened to infringe a patent protecting its schizophrenia treatments by ignoring its request for an undertaking that Juno would not supply or cause the PBS listing of any of its products in Australia before the expiry of the patent.

According to a report in Lawyerly, J&J is accusing Juno - which is now part of Arrotex - of intending to apply for PBS listing of the products.